| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2024 |
Barden A, Shinde S, Beilin LJ, Phillips M, Adams L, Bollmann S, Mori TA. Adiposity associates with lower plasma resolvin E1 (Rve1): a population study. International Journal of Obesity (2005). PMID 38347128 DOI: 10.1038/s41366-024-01482-x |
0.01 |
|
| 2024 |
Hagström H, Adams LA, Allen AM, Byrne CD, Chang Y, Duseja A, Grønbæk H, Ismail MH, Jepsen P, Kanwal F, Kramer J, Loomba R, Mark HE, Newsome PN, Rinella ME, et al. The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement. Hepatology Communications. 8. PMID 38315102 DOI: 10.1097/HC9.0000000000000386 |
0.01 |
|
| 2024 |
Jayawardena T, Attree C, Cole S, Hui S, Jaques B, MacQuillan G, Smith B, Wallace M, Garas G, Adams L, Jeffrey G. Successful Liver Retransplantation in a Patient With Disseminated Aspergillosis and Nocardiosis: A Case Report. Transplantation Proceedings. PMID 38218696 DOI: 10.1016/j.transproceed.2023.11.005 |
0.01 |
|
| 2023 |
Valenti L, Corradini E, Adams LA, Aigner E, Alqahtani S, Arrese M, Bardou-Jacquet E, Bugianesi E, Fernandez-Real JM, Girelli D, Hagström H, Henninger B, Kowdley K, Ligabue G, McClain D, et al. Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia. Nature Reviews. Endocrinology. PMID 38097672 DOI: 10.1038/s41574-023-00940-2 |
0.01 |
|
| 2023 |
Jeffrey AW, Adams LA. Recent advances in fibrosis assessment for metabolic dysfunction-associated fatty liver disease. Alimentary Pharmacology & Therapeutics. 58: 636-637. PMID 37632279 DOI: 10.1111/apt.17651 |
0.01 |
|
| 2023 |
Properzi C, Adams LA, Lo J, Sherriff JL, Jeffrey GP, O'Sullivan TA. Higher Overall Intakes Are the Defining Feature of Dietary Intakes in NAFLD and Compared to the General Population. Nutrients. 15. PMID 37375573 DOI: 10.3390/nu15122669 |
0.01 |
|
| 2023 |
Wang Z, Jeffrey GP, Huang Y, De Boer B, Garas G, Wallace M, Bertot L, Adams LA. Liver fibrosis quantified by image morphometry predicts clinical outcomes in patients with non-alcoholic fatty liver disease. Hepatology International. PMID 37358741 DOI: 10.1007/s12072-023-10564-3 |
0.01 |
|
| 2023 |
Adams LA, Schulte PJ, Allen AM. Use of non-invasive scores to predict hepatic steatosis: Flaws and caveats. Hepatology (Baltimore, Md.). PMID 37185880 DOI: 10.1097/HEP.0000000000000419 |
0.01 |
|
| 2023 |
Canivet CM, Zheng MH, Qadri S, Vonghia L, Chuah KH, Costentin C, George J, Armandi A, Adams LA, Lange NF, Blanchet O, Moal V, Younes R, Roux M, Chan WK, et al. Validation of the blood test MACK-3 for the noninvasive diagnosis of fibrotic NASH: an international study with 1,924 patients. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 37031715 DOI: 10.1016/j.cgh.2023.03.032 |
0.01 |
|
| 2023 |
Bertot LC, Jeffrey GP, Wang Z, Huang Y, Garas G, Wallace M, de Boer B, George J, Eslam M, Phu A, Ampuero J, Lucena Valera A, Gomez MR, Aller de la Fuente R, Adams LA. Predicting liver-related events in non-alcoholic fatty liver disease: a novel predictive model. Hepatology (Baltimore, Md.). PMID 36994693 DOI: 10.1097/HEP.0000000000000356 |
0.01 |
|
| 2023 |
Bertot LC, Jeffrey GP, de Boer B, Wang Z, Huang Y, Garas G, MacQuillan G, Wallace M, Smith BW, Adams LA. Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan® to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences. PMID 36947289 DOI: 10.1007/s10620-023-07896-3 |
0.01 |
|
| 2023 |
Valenti L, Corradini E, Adams LA, Aigner E, Alqahtani S, Arrese M, Bardou-Jacquet E, Bugianesi E, Fernandez-Real JM, Girelli D, Hagström H, Henninger B, Kowdley K, Ligabue G, McClain D, et al. Consensus Statement on the definition and classification of metabolic hyperferritinaemia. Nature Reviews. Endocrinology. 1-12. PMID 36805052 DOI: 10.1038/s41574-023-00807-6 |
0.01 |
|
| 2023 |
Adams LA. Cardiovascular disease in metabolic-associated fatty liver disease. Current Opinion in Endocrinology, Diabetes, and Obesity. 30: 81-86. PMID 36779252 DOI: 10.1097/MED.0000000000000803 |
0.01 |
|
| 2022 |
Howell J, Majumdar A, Fink M, Byrne M, McCaughan G, Strasser SI, Crawford M, Hodgkinson P, Stuart KA, Tallis C, Chen J, Wigg A, Jones R, Jaques B, Jeffrey G, ... Adams L, et al. The Hidden Epidemic: The Prevalence and Impact of Concurrent Liver Diseases in Patients Undergoing Liver Transplantation in Australia and New Zealand. Transplantation Direct. 8: e1345. PMID 37077731 DOI: 10.1097/TXD.0000000000001345 |
0.01 |
|
| 2022 |
Lazarus JV, Castera L, Mark HE, Allen AM, Adams LA, Anstee QM, Arrese M, Alqahtani SA, Bugianesi E, Colombo M, Cusi K, Hagström H, Loomba R, Romero-Gómez M, Schattenberg JM, et al. Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice. Jhep Reports : Innovation in Hepatology. 5: 100596. PMID 36644239 DOI: 10.1016/j.jhepr.2022.100596 |
0.01 |
|
| 2022 |
Alharthi J, Bayoumi A, Thabet K, Pan Z, Gloss BS, Latchoumanin O, Lundberg M, Twine NA, McLeod D, Alenizi S, Adams LA, Weltman M, Berg T, Liddle C, George J, et al. A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes. Nature Communications. 13: 7430. PMID 36473860 DOI: 10.1038/s41467-022-35158-9 |
0.01 |
|
| 2022 |
Adams LA. Metabolic Health and Outcomes in Fatty Liver: Does a Name Change Matter? Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 36462756 DOI: 10.1016/j.cgh.2022.11.028 |
0.01 |
|
| 2022 |
Berman YE, Doherty DA, Mori TA, Beilin LJ, Ayonrinde OT, Adams LA, Huang RC, Olynyk JK, Keelan JA, Newnham JP, Hart RJ. Associations between Prenatal Exposure to Phthalates and Features of the Metabolic Syndrome in Males from Childhood into Adulthood. International Journal of Environmental Research and Public Health. 19. PMID 36429961 DOI: 10.3390/ijerph192215244 |
0.01 |
|
| 2022 |
Yip TC, Vilar-Gomez E, Petta S, Yilmaz Y, Wong GL, Adams LA, de Lédinghen V, Sookoian S, Wong VW. Geographical similarity and differences in the burden and genetic predisposition of NAFLD. Hepatology (Baltimore, Md.). PMID 36062393 DOI: 10.1002/hep.32774 |
0.01 |
|
| 2022 |
Wan F, Pan F, Ayonrinde O, Adams LA, Mori TA, Beilin LJ, O'Sullivan TA, Olynyk JK, Oddy WH. Prospective dietary polyunsaturated fatty acid intake is associated with trajectories of fatty liver disease: an 8 year follow-up study from adolescence to young adulthood. European Journal of Nutrition. PMID 35780424 DOI: 10.1007/s00394-022-02934-8 |
0.01 |
|
| 2022 |
Hudert CA, Adams LA, Alisi A, Anstee QM, Crudele A, Draijer LG, Furse S, Hengstler JG, Jenkins B, Karnebeek K, Kelly DA, Koot BG, Koulman A, Meierhofer D, Melton PE, et al. Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17-beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms. Hepatology Communications. PMID 35411667 DOI: 10.1002/hep4.1955 |
0.01 |
|
| 2021 |
Janjua M, Knuiman M, Divitini M, McQuillan B, Olynyk JK, Jeffrey GP, Adams LA. Alcohol Consumption and Cardiovascular Outcomes in Patients With Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study. Hepatology Communications. PMID 34931492 DOI: 10.1002/hep4.1828 |
0.01 |
|
| 2021 |
Wang Z, Bertot LC, Jeffrey GP, Joseph J, Garas G, de Boer B, Huang Y, MacQuillan G, Wallace M, Smith B, Adams LA. Serum fibrosis tests guide prognosis in metabolic dysfunction associated fatty liver disease patients referred from primary care. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 34624564 DOI: 10.1016/j.cgh.2021.09.040 |
0.01 |
|
| 2021 |
Howell J, Majumdar A, Fink M, Byrne M, McCaughan G, Strasser SI, Crawford M, Hodgkinson P, Stuart KA, Tallis C, Chen J, Wigg A, Jones R, Jaques B, Jeffrey G, ... Adams L, et al. Turning the tide on hepatitis C-related liver transplantation: the return on investment in hepatitis C treatment in Australia and New Zealand. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. PMID 34624175 DOI: 10.1002/lt.26329 |
0.01 |
|
| 2021 |
Kanwal F, Shubrook JH, Adams LA, Pfotenhauer K, Wai-Sun Wong V, Wright E, Abdelmalek MF, Harrison SA, Loomba R, Mantzoros CS, Bugianesi E, Eckel RH, Kaplan LM, El-Serag HB, Cusi K. Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. PMID 34602251 DOI: 10.1053/j.gastro.2021.07.049 |
0.01 |
|
| 2021 |
Metwally M, Bayoumi A, Khan A, Adams LA, Aller R, García-Monzón C, Arias-Loste MT, Bugianesi E, Miele L, Anna A, Latchoumanin O, Han S, Alenizi S, Sharkawy RE, Elattar A, et al. Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease. Ebiomedicine. 70: 103521. PMID 34388518 DOI: 10.1016/j.ebiom.2021.103521 |
0.01 |
|
| 2021 |
Adams LA. The weighty issue of treating obesity in patients with non-alcoholic fatty liver disease. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 34175461 DOI: 10.1016/j.cgh.2021.06.021 |
0.01 |
|
| 2021 |
Bayoumi A, Elsayed A, Han S, Petta S, Adams LA, Aller R, Khan A, García-Monzón C, Arias-Loste MT, Miele L, Latchoumanin O, Alenizi S, Gallego-Durán R, Fischer J, Berg T, et al. Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 8: 2004168. PMID 34141520 DOI: 10.1002/advs.202004168 |
0.01 |
|
| 2021 |
Carnagarin R, Tan K, Adams L, Matthews VB, Kiuchi MG, Marisol Lugo Gavidia L, Lambert GW, Lambert EA, Herat LY, Schlaich MP. Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-A Condition Associated with Heightened Sympathetic Activation. International Journal of Molecular Sciences. 22. PMID 33921881 DOI: 10.3390/ijms22084241 |
0.01 |
|
| 2021 |
Carnagarin R, Kiuchi MG, Goh G, Adams L, Cohen N, Kavnoudias H, Gan SK, Van Schie G, Esler MD, Matthews VB, Schlaich MP. Role of the sympathetic nervous system in cardiometabolic control: implications for targeted multiorgan neuromodulation approaches. Journal of Hypertension. PMID 33657580 DOI: 10.1097/HJH.0000000000002839 |
0.01 |
|
| 2021 |
Kiuchi MG, Ganesan K, Keating J, Carnagarin R, Matthews VB, Herat LY, Goh G, Adams L, Schlaich MP. Combined renal and common hepatic artery denervation as a novel approach to reduce cardiometabolic risk: technical approach, feasibility and safety in a pre-clinical model. Clinical Research in Cardiology : Official Journal of the German Cardiac Society. PMID 33635438 DOI: 10.1007/s00392-021-01814-1 |
0.01 |
|
| 2021 |
Hagström H, Adams LA, Allen AM, Byrne CD, Chang Y, Grønbaek H, Ismail M, Jepsen P, Kanwal F, Kramer J, Lazarus JV, Long MT, Loomba R, Newsome PN, Rowe IA, et al. Administrative coding in electronic health care record-based research of NAFLD: an expert panel consensus statement. Hepatology (Baltimore, Md.). PMID 33486773 DOI: 10.1002/hep.31726 |
0.01 |
|
| 2020 |
Smith C, Lewis JR, Sim M, Lim WH, Lim EM, Blekkenhorst LC, Brennan-Speranza TC, Adams L, Byrnes E, Duque G, Levinger I, Prince RL. Higher Undercarboxylated to Total Osteocalcin Ratio Is Associated With Reduced Physical Function and Increased 15-Year Falls-Related Hospitalizations: The Perth Longitudinal Study of Aging Women. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 33615560 DOI: 10.1002/jbmr.4208 |
0.01 |
|
| 2020 |
Wan F, Pan F, Ayonrinde OT, Adams LA, Mori TA, Beilin LJ, O'Sullivan TA, Olynyk JK, Oddy WH. Validation of fatty liver disease scoring systems for ultrasound diagnosed non-alcoholic fatty liver disease in adolescents. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. PMID 33334704 DOI: 10.1016/j.dld.2020.11.037 |
0.01 |
|
| 2020 |
Wang Z, Huang Y, Nossent H, Chan JJ, Adams LA, Joseph J, Cheng W, Garas G, MacQuillan G, Jeffrey GP. Hepascore predicts liver outcomes and all-cause mortality in long-term methotrexate users: A retrospective cohort study. Jgh Open : An Open Access Journal of Gastroenterology and Hepatology. 4: 1211-1216. PMID 33319058 DOI: 10.1002/jgh3.12430 |
0.01 |
|
| 2020 |
Bayoumi A, Jalil I, Metwally M, Adams LA, Aller R, García-Monzón C, Arias-Loste MT, Miele L, Petta S, Craxì A, Gallego-Durán R, Fischer J, Berg T, Qiao L, Liddle C, et al. Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease. Plos One. 15: e0243590. PMID 33306709 DOI: 10.1371/journal.pone.0243590 |
0.01 |
|
| 2020 |
Calzadilla-Bertot L, Vilar-Gomez E, George J, Adams LA. Reply to Letter to the Editor HEP-20-2462 and HEP-20-2655. Hepatology (Baltimore, Md.). PMID 33277720 DOI: 10.1002/hep.31666 |
0.01 |
|
| 2020 |
Davis TME, Peters KE, Chubb SAP, Adams LA, Jeffrey GP, Davis WA. Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes Study. Journal of Clinical Medicine. 9. PMID 33114323 DOI: 10.3390/jcm9113409 |
0.01 |
|
| 2020 |
Eslam M, Sarin SK, Wong VW, Fan JG, Kawaguchi T, Ahn SH, Zheng MH, Shiha G, Yilmaz Y, Gani R, Alam S, Dan YY, Kao JH, Hamid S, Cua IH, ... ... Adams LA, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatology International. PMID 33006093 DOI: 10.1007/s12072-020-10094-2 |
0.01 |
|
| 2020 |
Chin J, Mori TA, Adams LA, Beilin LJ, Huang RC, Olynyk JK, Ayonrinde OT. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents. Jhep Reports : Innovation in Hepatology. 2: 100150. PMID 32984791 DOI: 10.1016/j.jhepr.2020.100150 |
0.01 |
|
| 2020 |
Calzadilla-Bertot L, Vilar-Gomez E, Wong VW, Romero-Gomez M, Aller-de la Fuente R, Wong GL, Castellanos M, Eslam M, Desai AP, Jeffrey GP, George J, Chalasani N, Adams LA. ABIDE: an accurate predictive model of liver decompensation in patients with non-alcoholic fatty liver-related cirrhosis. Hepatology (Baltimore, Md.). PMID 32978796 DOI: 10.1002/hep.31576 |
0.01 |
|
| 2020 |
Drak D, Tangirala N, Fink M, Adams LA, Fawcett J, Jeffrey GP, Byrne M, McCaughan G, Chadban S, Wyburn K, Wong G, Lim WH, Gracey DM. Trends and Outcomes in Simultaneous Liver and Kidney Transplantation in Australia and New Zealand. Transplantation Proceedings. PMID 32933766 DOI: 10.1016/j.transproceed.2020.08.030 |
0.01 |
|
| 2020 |
Teo K, Abeysekera KWM, Adams L, Aigner E, Anstee QM, Banales JM, Banerjee R, Basu P, Berg T, Bhatnagar P, Buch S, Canbay A, Caprio S, Chatterjee A, Ida Chen YD, et al. rs641738C>T near MBOAT7 is associated with liver fat, ALT, and fibrosis in NAFLD: a meta-analysis. Journal of Hepatology. PMID 32882372 DOI: 10.1016/J.Jhep.2020.08.027 |
0.01 |
|
| 2020 |
Gaul S, Leszczynska A, Alegre F, Kaufmann B, Johnson CD, Adams LA, Wree A, Damm G, Seehofer D, Calvente CJ, Povero D, Kisseleva T, Eguchi A, McGeough MD, Hoffman HM, et al. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. Journal of Hepatology. PMID 32763266 DOI: 10.1016/j.jhep.2020.07.041 |
0.01 |
|
| 2020 |
Adams LA, Chan WK. Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future. Seminars in Liver Disease. PMID 32526784 DOI: 10.1055/s-0040-1713006 |
0.01 |
|
| 2020 |
Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, Aller-de la Fuente R, Eslam M, Lai-Hung Wong G, George J, Romero-Gomez M, Adams LA. Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Non-alcoholic Steatohepatitis-related, Child-Pugh A Cirrhosis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 32389886 DOI: 10.1016/j.cgh.2020.04.083 |
0.01 |
|
| 2020 |
Teeratorn N, Piyachaturawat P, Thanapirom K, Chaiteerakij R, Sonsiri K, Komolmit P, Tangkijvanich P, Rerknimitr R, Adams L, Treeprasertsuk S. Screening for non-alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter-transient elastography. Jgh Open : An Open Access Journal of Gastroenterology and Hepatology. 4: 245-250. PMID 32280772 DOI: 10.1002/jgh3.12252 |
0.01 |
|
| 2020 |
Eslam M, Newsome PN, Anstee QM, Targher G, Gomez MR, Zelber-Sagi S, Wong VW, Dufour JF, Schattenberg J, Arrese M, Valenti L, Shiha G, Tiribelli C, Yki-Järvinen H, Fan JG, ... ... Adams LA, et al. A new definition for metabolic associated fatty liver disease: an international expert consensus statement. Journal of Hepatology. PMID 32278004 DOI: 10.1016/j.jhep.2020.03.039 |
0.01 |
|
| 2020 |
Dave S, Park S, Murad MH, Barnard A, Prokop L, Adams LA, Singh S, Loomba R. Comparative Effectiveness of Entecavir vs Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: a Systematic Review and Meta-analysis. Hepatology (Baltimore, Md.). PMID 32277491 DOI: 10.1002/hep.31267 |
0.01 |
|
| 2020 |
Adams LA, Wang Z, Liddle C, Melton PE, Ariff A, Chandraratna H, Tan J, Ching H, Coulter S, de Boer B, Christophersen CT, O'Sullivan TA, Morrison M, Jeffrey GP. Bile acids associate with specific gut microbiota, low level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 32243703 DOI: 10.1111/Liv.14453 |
0.01 |
|
| 2020 |
Loomba R, Adams LA. Advances in non-invasive assessment of hepatic fibrosis. Gut. PMID 32066623 DOI: 10.1136/gutjnl-2018-317593 |
0.01 |
|
| 2020 |
Adams LA, Roberts SK, Strasser SI, Mahady SE, Powell E, Estes C, Razavi H, George J. NAFLD Disease Burden - Australia, 2019-2030. Journal of Gastroenterology and Hepatology. PMID 32048317 DOI: 10.1111/jgh.15009 |
0.01 |
|
| 2020 |
Wallace MC, Samuelson S, Khoo T, Ooi J, Tibballs J, Ferguson J, Preen DB, Knuiman M, Garas G, MacQuillan G, Adams LA, Jeffrey GP. The MAAPE score in intermediate and advanced hepatocellular carcinoma treated with Yttrium-90 resin microsphere radioembolization. Journal of Gastroenterology and Hepatology. PMID 32036614 DOI: 10.1111/jgh.15008 |
0.01 |
|
| 2020 |
Ayonrinde OT, Ayonrinde OA, Adams LA, Sanfilippo FM, O' Sullivan TA, Robinson M, Oddy WH, Olynyk JK. The relationship between abdominal pain and emotional wellbeing in children and adolescents in the Raine Study. Scientific Reports. 10: 1646. PMID 32015372 DOI: 10.1038/s41598-020-58543-0 |
0.01 |
|
| 2019 |
Hallsworth K, Adams LA. Lifestyle modification in NAFLD/NASH: Facts and figures. Jhep Reports (Online). 1: 468-479. PMID 32039399 DOI: 10.1016/j.jhepr.2019.10.008 |
0.01 |
|
| 2019 |
Mitchell T, McKinnon E, Ayonrinde O, Adams LA, Trinder D, Chua ACG, Newton RU, Straker L, Olynyk JK. Decreased Physical Working Capacity in Adolescents With Non-Alcoholic Fatty Liver Disease Associates With Reduced Iron Availability: PWC in NAFLD Relates to Iron Bioavailability. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 31628998 DOI: 10.1016/j.cgh.2019.10.017 |
0.01 |
|
| 2019 |
Pai RK, Kleiner DE, Hart J, Adeyi OA, Clouston AD, Behling CA, Jain D, Kakar S, Brahmania M, Burgart L, Batts KP, Valasek MA, Torbenson MS, Guindi M, Wang HL, ... ... Adams LA, et al. Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trials. Alimentary Pharmacology & Therapeutics. PMID 31583739 DOI: 10.1111/Apt.15503 |
0.01 |
|
| 2019 |
Loomba R, Adams LA. Editorial: The 20% Rule of NASH Progression: The Natural History of Advanced Fibrosis and Cirrhosis due to NASH. Hepatology (Baltimore, Md.). PMID 31520407 DOI: 10.1002/hep.30946 |
0.01 |
|
| 2019 |
Chen F, Esmaili S, Rogers G, Bugianesi E, Petta S, Marchesini G, Bayoumi A, Metwally M, Azardaryany MK, Coulter S, Choo JM, Younes R, Rosso C, Liddle C, Adams LA, et al. Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation. Hepatology (Baltimore, Md.). PMID 31442319 DOI: 10.1002/hep.30908 |
0.01 |
|
| 2019 |
Wallace MC, Sek K, Francis RJ, Samuelson S, Ferguson J, Tibballs J, Asad A, Preen DB, MacQuillan G, Garas G, Adams LA, Jeffrey GP. Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy. Digestive Diseases and Sciences. PMID 31440998 DOI: 10.1007/s10620-019-05781-6 |
0.01 |
|
| 2019 |
Lewis JR, Brennan-Speranza TC, Levinger I, Byrnes E, Lim EM, Blekkenhorst LC, Sim M, Hodgson JM, Zhu K, Lim WH, Adams LA, Prince RL. Effects of calcium supplementation on circulating osteocalcin and glycated haemoglobin in older women. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. PMID 31342138 DOI: 10.1007/s00198-019-05087-3 |
0.01 |
|
| 2019 |
Huang Y, Joseph J, de Boer WB, Cheng W, Adams LA, MacQuillan G, Garas G, Raftopoulos S, Jeffrey GP. Long-term Liver-related Outcomes of Patients with Chronic Liver Diseases in Australia. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 31319186 DOI: 10.1016/j.cgh.2019.07.013 |
0.01 |
|
| 2019 |
Adams LA. Correction to: End-points for drug treatment in NASH. Hepatology International. PMID 31073971 DOI: 10.1007/s12072-019-09949-0 |
0.01 |
|
| 2019 |
Ayonrinde OT, Sanfilippo FM, O'Sullivan TA, Adams LA, Ayonrinde OA, Robinson M, Oddy WH, Olynyk JK. Bowel patterns, gastrointestinal symptoms and emotional well-being in adolescents - A cohort study. Journal of Gastroenterology and Hepatology. PMID 31059144 DOI: 10.1111/jgh.14699 |
0.01 |
|
| 2019 |
Bertot LC, Adams LA. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology. 13: 179-187. PMID 30791782 DOI: 10.1080/17474124.2019.1549989 |
0.01 |
|
| 2019 |
Adams LA. Mini-review: end-points for drug treatment in NASH. Hepatology International. PMID 30783901 DOI: 10.1007/s12072-019-09935-6 |
0.01 |
|
| 2019 |
Calzadilla-Bertot L, Jeffrey GP, Jacques B, McCaughan G, Crawford M, Angus P, Jones R, Gane E, Munn S, Macdonald G, Fawcett J, Wigg A, Chen J, Fink M, Adams LA. Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New Zealand. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 25: 25-34. PMID 30609187 DOI: 10.1002/Lt.25361 |
0.01 |
|
| 2018 |
Hart RJ, Doherty DA, Mori TA, Adams LA, Huang RC, Minaee N, Handelsman DJ, McLachlan R, Norman RJ, Dickinson JE, Olynyk JK, Beilin LJ. Features of the metabolic syndrome in late adolescence are associated with impaired testicular function at 20 years of age. Human Reproduction (Oxford, England). PMID 30576537 DOI: 10.1093/humrep/dey371 |
0.01 |
|
| 2018 |
Wong VWS, Adams LA. Fibroblast growth factor 21 for non-alcoholic steatohepatitis. Lancet (London, England). PMID 30554786 DOI: 10.1016/S0140-6736(18)32165-2 |
0.01 |
|
| 2018 |
Metwally M, Bayoumi A, Romero-Gomez M, Thabet K, John M, Adams LA, Huo X, Aller R, García-Monzón C, Arias-Loste MT, Bugianesi E, Miele L, Gallego-Durán R, Fischer J, Berg T, et al. A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR. Journal of Hepatology. PMID 30389552 DOI: 10.1016/j.jhep.2018.10.021 |
0.01 |
|
| 2018 |
Alkhouri N, Johnson C, Adams L, Kitajima S, Tsuruno C, Colpitts TL, Hatcho K, Lawitz E, Lopez R, Feldstein AE. Correction: Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis. Plos One. 13: e0205541. PMID 30286196 DOI: 10.1371/Journal.Pone.0205541 |
0.01 |
|
| 2018 |
Ramlaul N, Ooi J, Jeffrey GP, MacQuillan G, Garas G, Adams LA, Iqbal M, Nolan N, Houlihan DD, McCormick A, Mac Nicholas R. Rapid recurrence of CVID related cholangiopathy and poor outcomes following liver transplantation. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. PMID 30260552 DOI: 10.1002/lt.25343 |
0.01 |
|
| 2018 |
Wallace MC, Preen DB, Short MW, Adams LA, Jeffrey GP. Hepatocellular carcinoma in Australia 1982 to 2014: increasing incidence and improving survival. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 30230194 DOI: 10.1111/liv.13966 |
0.01 |
|
| 2018 |
Alkhouri N, Johnson C, Adams L, Kitajima S, Tsuruno C, Colpitts TL, Hatcho K, Lawitz E, Lopez R, Feldstein A. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis. Plos One. 13: e0202226. PMID 30161179 DOI: 10.1371/journal.pone.0202226 |
0.01 |
|
| 2018 |
Daniels SJ, Leeming DJ, Eslam M, Hashem AM, Nielsen MJ, Krag A, Karsdal MA, Grove JI, Guha IN, Kawaguchi T, Torimura T, McLeod D, Akiba J, Kaye P, de Boer B, ... ... Adams LA, et al. ADAPT: An algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis. Hepatology (Baltimore, Md.). PMID 30014517 DOI: 10.1002/hep.30163 |
0.01 |
|
| 2018 |
Mitchell T, Jeffrey GP, de Boer B, MacQuillan G, Garas G, Ching H, Hamdorf J, Adams LA. Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease. The American Journal of Gastroenterology. PMID 29899440 DOI: 10.1038/s41395-018-0133-5 |
0.01 |
|
| 2018 |
Britton L, Bridle K, Reiling J, Santrampurwala N, Wockner L, Ching H, Stuart K, Subramaniam VN, Jeffrey G, St Pierre T, House M, Gummer J, Trengove R, Olynyk J, Crawford D, ... Adams L, et al. Hepatic iron concentration correlates with insulin sensitivity in nonalcoholic fatty liver disease. Hepatology Communications. 2: 644-653. PMID 29881816 DOI: 10.1002/hep4.1190 |
0.01 |
|
| 2018 |
Mahady SE, Adams LA. Burden of non-alcoholic fatty liver disease in Australia. Journal of Gastroenterology and Hepatology. 33: 1-11. PMID 29851153 DOI: 10.1111/jgh.14270 |
0.01 |
|
| 2018 |
Wong VW, Adams LA, de Lédinghen V, Wong GL, Sookoian S. Noninvasive biomarkers in NAFLD and NASH - current progress and future promise. Nature Reviews. Gastroenterology & Hepatology. PMID 29844588 DOI: 10.1038/s41575-018-0014-9 |
0.01 |
|
| 2018 |
Wallace MC, Knuiman M, Huang Y, Garas G, Adams LA, MacQuillan G, Preen DB, Jeffrey GP. The Prognostic Ability of Major Hepatocellular Carcinoma Staging Systems Is Improved by Including a Treatment Variable. Digestive Diseases and Sciences. PMID 29808245 DOI: 10.1007/s10620-018-5132-2 |
0.01 |
|
| 2018 |
Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, Aller-de la Fuente R, Metwally M, Eslam M, Gonzalez-Fabian L, Alvarez-Quiñones Sanz M, Conde-Martin AF, De Boer B, McLeod D, Hung Chan AW, Chalasani N, George J, ... Adams LA, et al. Fibrosis Severity as a Determinant of Cause-specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease. Gastroenterology. PMID 29733831 DOI: 10.1053/j.gastro.2018.04.034 |
0.01 |
|
| 2018 |
Properzi C, O'Sullivan TA, Sherriff JL, Ching HL, Jeffrey GP, Buckley RF, Tibballs J, MacQuillan GC, Garas G, Adams LA. Ad libitum Mediterranean and Low Fat Diets both Significantly Reduce Hepatic Steatosis: a Randomized Controlled Trial. Hepatology (Baltimore, Md.). PMID 29729189 DOI: 10.1002/hep.30076 |
0.01 |
|
| 2018 |
Bertot LC, Jeffrey GP, de Boer B, MacQuillan G, Garas G, Chin J, Huang Y, Adams LA. Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 29575516 DOI: 10.1111/liv.13739 |
0.01 |
|
| 2018 |
Ma MX, Huang Y, Adams LA, Gilpin R, Garas G, MacQuillan G, Jeffrey GP, Nicholas RM. Prevalence of restless legs syndrome in a tertiary cohort of ambulant patients with chronic liver disease. Internal Medicine Journal. 48: 347-350. PMID 29512318 DOI: 10.1111/imj.13719 |
0.01 |
|
| 2018 |
House M, Lai L, Chan W, Mustapha N, Vijayananthan A, Mahadeva S, Adams L, Olynyk J, Boulos S, Pierre T. A non-invasive biomarker of hepatic inflammation based on magnetic resonance imaging Journal of Hepatology. 68: S565. DOI: 10.1016/S0168-8278(18)31387-4 |
0.01 |
|
| 2018 |
Ng D, Hooper A, Bell D, Wallace M, Adams L, Burnett J. Non-Alcoholic Steatohepatitis in APOB C.2999+1G > A Familial Hypobetalipoproteinaemia Heart, Lung and Circulation. 27: S363. DOI: 10.1016/J.HLC.2018.06.719 |
0.01 |
|
| 2017 |
Bertot LC, Jeffrey GP, Wallace M, MacQuillan G, Garas G, Ching HL, Adams LA. Nonalcoholic fatty liver disease-related cirrhosis is commonly unrecognized and associated with hepatocellular carcinoma. Hepatology Communications. 1: 53-60. PMID 29404433 DOI: 10.1002/hep4.1018 |
0.01 |
|
| 2017 |
Huang Y, Wallace MC, Adams LA, MacQuillan G, Garas G, Ferguson J, Samuelson S, Tibballs J, Jeffrey GP. Rate of Nonsurveillance and Advanced Hepatocellular Carcinoma at Diagnosis in Chronic Liver Disease. Journal of Clinical Gastroenterology. PMID 28858944 DOI: 10.1097/MCG.0000000000000916 |
0.01 |
|
| 2017 |
Jeffrey AW, Huang Y, de Boer WB, Adams LA, MacQuillan G, Speers D, Joseph J, Jeffrey GP. Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome. World Journal of Hepatology. 9: 850-856. PMID 28740596 DOI: 10.4254/wjh.v9.i19.850 |
0.01 |
|
| 2017 |
Mridha AR, Haczeyni F, Yeh MM, Haigh WG, Ioannou GN, Barn V, Ajamieh H, Adams L, Hamdorf JM, Teoh NC, Farrell GC. TLR9 is upregulated in human and murine NASH: pivotal role for inflammatory recruitment and cell survival. Clinical Science (London, England : 1979). PMID 28687713 DOI: 10.1042/CS20160838 |
0.01 |
|
| 2017 |
Ayonrinde OT, Adams LA, Mori TA, Beilin LJ, de Klerk N, Pennell CE, White S, Olynyk JK. Gender differences between parental pregnancy characteristics and nonalcoholic fatty liver disease in adolescents. Hepatology (Baltimore, Md.). PMID 28665032 DOI: 10.1002/hep.29347 |
0.01 |
|
| 2017 |
White SW, Eastwood PR, Straker LM, Adams LA, Newnham JP, Lye SJ, Pennell CE. The Raine study had no evidence of significant perinatal selection bias after two decades of follow up: a longitudinal pregnancy cohort study. Bmc Pregnancy and Childbirth. 17: 207. PMID 28662683 DOI: 10.1186/s12884-017-1391-8 |
0.01 |
|
| 2017 |
Ayonrinde OT, Oddy WH, Adams LA, Mori TA, Beilin LJ, de Klerk N, Olynyk JK. Infant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescents. Journal of Hepatology. PMID 28619255 DOI: 10.1016/j.jhep.2017.03.029 |
0.01 |
|
| 2017 |
Wallace MC, Huang Y, Preen DB, Garas G, Adams LA, MacQuillan G, Tibballs J, Ferguson J, Samuelson S, Jeffrey GP. HKLC Triages More Hepatocellular Carcinoma Patients to Curative Therapies Compared to BCLC and Is Associated with Better Survival. Digestive Diseases and Sciences. PMID 28547649 DOI: 10.1007/s10620-017-4622-y |
0.01 |
|
| 2017 |
Vilar-Gomez E, Calzadilla-Bertot L, Friedman SL, Gra-Oramas B, Gonzalez-Fabian L, Vallin SL, Diago M, Adams LA. Serum biomarkers can predict a change in liver fibrosis one year after lifestyle intervention for biopsy-proven NASH. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 28544769 DOI: 10.1111/liv.13480 |
0.01 |
|
| 2017 |
Cartland SP, Harith HH, Genner SW, Dang L, Cogger VC, Vellozzi M, Di Bartolo BA, Thomas SR, Adams LA, Kavurma MM. Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice. Scientific Reports. 7: 1898. PMID 28507343 DOI: 10.1038/s41598-017-01721-4 |
0.01 |
|
| 2017 |
Khoo T, Jeffrey G, Garas G, MacQuillan G, Adams L, Samuelson S. Plug-assisted retrograde transvenous obliteration of splenorenal shunts for refractory hepatic encephalopathy. Internal Medicine Journal. 47: 470-471. PMID 28401727 DOI: 10.1111/imj.13395 |
0.01 |
|
| 2017 |
Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. PMID 28314735 DOI: 10.1136/gutjnl-2017-313884 |
0.01 |
|
| 2017 |
Adams LA, Sterling RK. Developing a new algorithm to diagnose advanced liver fibrosis: A lift or a nudge in the right direction? Journal of Hepatology. PMID 28219771 DOI: 10.1016/j.jhep.2017.02.011 |
0.01 |
|
| 2017 |
Pateria P, Jeffrey GP, Garas G, Tibballs J, Ferguson J, Delriviere L, Huang Y, Adams LA, MacQuillan G. Transjugular intrahepatic portosystemic shunt: Indications, complications, survival and its use as a bridging therapy to liver transplant in Western Australia. Journal of Medical Imaging and Radiation Oncology. PMID 28070962 DOI: 10.1111/1754-9485.12563 |
0.01 |
|
| 2017 |
Zhang H, Brewer K, Jeffrey G, Twigg S, McCaughan G, Williams K, Adams L, Gorrell M. Circulating Fibroblast Activation Protein activity as a liver fibrosis biomarker in NAFLD Journal of Hepatology. 66: S666-S667. DOI: 10.1016/S0168-8278(17)31802-0 |
0.01 |
|
| 2017 |
Gómez E, Aller R, Gallego-Durán R, Bañales J, Loste M, García-Monzón C, Ramirez H, García-Torres M, Gómez-Camarero J, Caballería J, Aguilar-Urbano V, Salmerón J, Calleja J, Abad J, Olcoz-Goñi J, ... ... Adams L, et al. Metabolic and biochemical phenotypes can distinguish different patterns of histological severity in biopsy-proven NAFLD Journal of Hepatology. 66: S155-S156. DOI: 10.1016/S0168-8278(17)30584-6 |
0.01 |
|
| 2017 |
Bertot LC, Adams LA. Role of Exercise in NAFLD/NASH: What is the Right Prescription? Current Hepatology Reports. 16: 356-365. DOI: 10.1007/s11901-017-0374-6 |
0.01 |
|
| 2016 |
Huang Y, MacQuillan G, Adams LA, Garas G, Collins M, Nwaba A, Mou L, Bulsara MK, Delriviere L, Jeffrey GP. Effect of airplane transport of donor livers on post-liver transplantation survival. World Journal of Gastroenterology. 22: 9154-9161. PMID 27895402 DOI: 10.3748/wjg.v22.i41.9154 |
0.01 |
|
| 2016 |
Vilar-Gomez E, Calzadilla-Bertot L, Friedman SL, Gra-Oramas B, Gonzalez-Fabian L, Villa-Jimenez O, Lazo-Del Vallin S, Diago M, Adams LA, Romero-Gomez M, Chalasani N. Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis. Alimentary Pharmacology & Therapeutics. PMID 27862096 DOI: 10.1111/apt.13860 |
0.01 |
|
| 2016 |
Mitchell T, Gooding H, Mews C, Adams L, MacQuillan G, Garas G, Ravikumara M, Lopez A, Collins M, Jeffrey G. Transition to adult care for pediatric liver transplant recipients: the Western Australian experience. Pediatric Transplantation. PMID 27762479 DOI: 10.1111/petr.12820 |
0.01 |
|
| 2016 |
Mitchell T, Chakera A, Jeffrey GP, Adams LA, Garas G, Jones T, MacQuillan G. Reversal of end-stage renal failure using direct-acting antiviral agents for chronic hepatitis C. The Medical Journal of Australia. 205: 205-6. PMID 27581262 DOI: 10.5694/mja16.00207 |
0.01 |
|
| 2016 |
St Pierre TG, House MJ, Bangma SJ, Pang W, Bathgate A, Gan EK, Ayonrinde OT, Bhathal PS, Clouston A, Olynyk JK, Adams LA. Stereological Analysis of Liver Biopsy Histology Sections as a Reference Standard for Validating Non-Invasive Liver Fat Fraction Measurements by MRI. Plos One. 11: e0160789. PMID 27501242 DOI: 10.1371/journal.pone.0160789 |
0.01 |
|
| 2016 |
Keating SE, Adams LA. Exercise in NAFLD: Just do it. Journal of Hepatology. PMID 27392426 DOI: 10.1016/j.jhep.2016.06.022 |
0.01 |
|
| 2016 |
Vilar-Gomez E, Adams LA. Pioglitazone: An Addition to Our Toolbox for Patients With Diabetes and Nonalcoholic Steatohepatitis? Annals of Internal Medicine. PMID 27322890 DOI: 10.7326/M16-1303 |
0.01 |
|
| 2016 |
Calzadilla Bertot L, Adams LA. The Natural Course of Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences. 17. PMID 27213358 DOI: 10.3390/ijms17050774 |
0.01 |
|
| 2016 |
Adams LA, Anstee QM. A Fatty liver leads to a broken heart? Journal of Hepatology. PMID 27025686 DOI: 10.1016/j.jhep.2016.03.012 |
0.01 |
|
| 2016 |
Huang Y, Adams LA, Joseph J, Bulsara M, Jeffrey GP. The Ability of Hepascore to Predict Liver Fibrosis in Chronic Liver Disease: a Meta-analysis. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 26991726 DOI: 10.1111/liv.13116 |
0.01 |
|
| 2016 |
Huang Y, Adams L, MacQuillan G, Speers D, Joseph J, Bulsara M, Jeffrey G. Serum models accurately predict liver related clinical outcomes in chronic hepatitis C. Journal of Gastroenterology and Hepatology. PMID 26945918 DOI: 10.1111/jgh.13333 |
0.01 |
|
| 2016 |
Eslam M, Mangia A, Berg T, Chan HL, Irving WL, Dore GJ, Abate ML, Bugianesi E, Adams LA, Najim MA, Miele L, Weltman M, Mollison L, Cheng W, Riordan S, et al. Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes. Hepatology (Baltimore, Md.). PMID 26822232 DOI: 10.1002/hep.28475 |
0.01 |
|
| 2016 |
Calzadilla-Bertot L, Vilar-Gomez E, Torres-Gonzalez A, Socias-Lopez M, Diago M, Adams LA, Romero-Gomez M. Impaired glucose metabolism increases risk of hepatic decompensation and death in patients with compensated hepatitis C virus-related cirrhosis. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. 48: 283-90. PMID 26797261 DOI: 10.1016/j.dld.2015.12.002 |
0.01 |
|
| 2016 |
Sherriff JL, O'Sullivan TA, Properzi C, Oddo JL, Adams LA. Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes. Advances in Nutrition (Bethesda, Md.). 7: 5-13. PMID 26773011 DOI: 10.3945/an.114.007955 |
0.01 |
|
| 2016 |
Ayonrinde O, Oddy W, Adams L, Mori T, Beilin L, Olynyk J. Maternal Obesity and Duration of Breastfeeding Influence the Risk of Non-Alcoholic Fatty Liver Disease in Adolescents Journal of Hepatology. 64: S491-S492. DOI: 10.1016/S0168-8278(16)00843-6 |
0.01 |
|
| 2016 |
Cartland S, Harith H, Vellozzi M, Genner S, Di Bartolo B, Dang L, Thomas S, Adams L, Kavurma M. Non-alcoholic Fatty Liver Disease (NAFLD) is Exacerbated with TRAIL Deletion, Associating with Vascular Inflammation and Insulin Resistance Heart, Lung and Circulation. 25: S89. DOI: 10.1016/J.HLC.2016.06.209 |
0.01 |
|
| 2016 |
Adams LA, Morrison M. The Microbiome in Obesity, Diabetes, and NAFLD: What is Your Gut Telling Us? Current Hepatology Reports. 15: 96-102. DOI: 10.1007/s11901-016-0299-5 |
0.01 |
|
| 2015 |
Eslam M, Hashem AM, Romero-Gomez M, Berg T, Dore GJ, Mangia A, Chan HL, Irving WL, Sheridan D, Abate ML, Adams LA, Weltman M, Bugianesi E, Spengler U, Shaker O, et al. FibroGENE: A gene-based model for staging liver fibrosis. Journal of Hepatology. PMID 26592354 DOI: 10.1016/j.jhep.2015.11.008 |
0.01 |
|
| 2015 |
Ayonrinde OT, Adams LA, Doherty DA, Mori TA, Beilin LJ, Oddy WH, Hickey M, Sloboda DM, Olynyk JK, Hart R. Adolescent females with NAFLD and PCOS have an adverse metabolic phenotype compared with other females and males. Journal of Gastroenterology and Hepatology. PMID 26589977 DOI: 10.1111/jgh.13241 |
0.01 |
|
| 2015 |
Adams LA, Arauz O, Angus PW, Sinclair M, MacDonald GA, Chelvaratnam U, Wigg AJ, Yeap S, Shackel N, Lin L, Raftopoulos S, McCaughan GW, Jeffrey GP. The additive impact of pre-liver transplant metabolic factors on survival post-liver transplant. Journal of Gastroenterology and Hepatology. PMID 26589875 DOI: 10.1111/jgh.13240 |
0.01 |
|
| 2015 |
Adams LA, Crawford DH, St Pierre TK, Olynyk JK. Reply. Hepatology (Baltimore, Md.). PMID 26238272 DOI: 10.1002/hep.28030 |
0.01 |
|
| 2015 |
Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, Keach JC, Lafferty HD, Stahler A, Haflidadottir S, Bendtsen F. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 149: 389-97.e10. PMID 25935633 DOI: 10.1053/j.gastro.2015.04.043 |
0.01 |
|
| 2015 |
Wallace MC, Preen D, Jeffrey GP, Adams LA. The evolving epidemiology of hepatocellular carcinoma: a global perspective. Expert Review of Gastroenterology & Hepatology. 9: 765-79. PMID 25827821 DOI: 10.1586/17474124.2015.1028363 |
0.01 |
|
| 2015 |
Eslam M, Hashem AM, Leung R, Romero-Gomez M, Berg T, Dore GJ, Chan HL, Irving WL, Sheridan D, Abate ML, Adams LA, Mangia A, Weltman M, Bugianesi E, Spengler U, et al. Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease. Nature Communications. 6: 6422. PMID 25740255 DOI: 10.1038/ncomms7422 |
0.01 |
|
| 2015 |
Speers DJ, Ma MX, Faddy HM, Nash M, Bowden S, de Boer B, MacNicholas R, MacQuillan G, Adams L. Domestically acquired hepatitis E successfully treated with ribavirin in an Australian liver transplant recipient. The Medical Journal of Australia. 202: 209-11. PMID 25716605 DOI: 10.5694/mja14.00453 |
0.01 |
|
| 2015 |
Adams LA, Ratziu V. Non-alcoholic fatty liver - perhaps not so benign. Journal of Hepatology. 62: 1002-4. PMID 25681555 DOI: 10.1016/j.jhep.2015.02.005 |
0.01 |
|
| 2015 |
Adams LA. NAFLD. Accurate quantification of hepatic fat--is it important? Nature Reviews. Gastroenterology & Hepatology. 12: 126-7. PMID 25666645 DOI: 10.1038/nrgastro.2015.23 |
0.01 |
|
| 2015 |
Ooi EM, Adams LA, Zhu K, Lewis JR, Kerr DA, Meng X, Solah V, Devine A, Binns CW, Prince RL. Consumption of a whey protein-enriched diet may prevent hepatic steatosis associated with weight gain in elderly women. Nutrition, Metabolism, and Cardiovascular Diseases : Nmcd. 25: 388-95. PMID 25638597 DOI: 10.1016/j.numecd.2014.11.005 |
0.01 |
|
| 2015 |
Bremner AP, O?Sullivan TA, Oddy WH, Sherriff JL, Ayonrinde OT, Olynyk JK, Beilin LJ, Mori TA, Adams LA. Authors' response. Journal of Pediatric Gastroenterology and Nutrition. 60: e35-6. PMID 25564814 DOI: 10.1097/MPG.0000000000000705 |
0.01 |
|
| 2015 |
Adams LA, Crawford DH, Stuart K, House MJ, St Pierre TG, Webb M, Ching HL, Kava J, Bynevelt M, MacQuillan GC, Garas G, Ayonrinde OT, Mori TA, Croft KD, Niu X, et al. The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial. Hepatology (Baltimore, Md.). 61: 1555-64. PMID 25524401 DOI: 10.1002/hep.27662 |
0.01 |
|
| 2015 |
Ayonrinde OT, Olynyk JK, Marsh JA, Beilin LJ, Mori TA, Oddy WH, Adams LA. Childhood adiposity trajectories and risk of nonalcoholic fatty liver disease in adolescents. Journal of Gastroenterology and Hepatology. 30: 163-71. PMID 24989077 DOI: 10.1111/jgh.12666 |
0.01 |
|
| 2015 |
House MJ, Bangma SJ, Thomas M, Gan EK, Ayonrinde OT, Adams LA, Olynyk JK, St Pierre TG. Texture-based classification of liver fibrosis using MRI. Journal of Magnetic Resonance Imaging : Jmri. 41: 322-8. PMID 24347292 DOI: 10.1002/jmri.24536 |
0.01 |
|
| 2015 |
St Pierre T, House M, Bangma S, Pang W, Gan E, Adams L, Ayonrinde O, Bhathal P, Olynyk J. P1014 : Assessing bias in a magnetic resonance imaging method for measurement of liver fat fraction Journal of Hepatology. 62: S727-S728. DOI: 10.1016/S0168-8278(15)31215-0 |
0.01 |
|
| 2014 |
Harding DJ, MacQuillan G, Howman R, de Boer B, Adams L, Mitchell A, Jeffrey G. Successful Use of Dasatinib After Liver Transplantation for Imatinib-Induced Fulminant Liver Failure in Chronic Myeloid Leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 25267743 DOI: 10.1200/JCO.2013.50.1320 |
0.01 |
|
| 2014 |
Chinnaratha MA, Chelvaratnam U, Stuart KA, Strasser SI, McCaughan GW, Gow P, Adams LA, Wigg AJ. Liver transplantation outcomes for Australian Aboriginal and Torres Strait Islanders. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 20: 798-806. PMID 24753233 DOI: 10.1002/lt.23894 |
0.01 |
|
| 2014 |
Black LJ, Jacoby P, She Ping-Delfos WC, Mori TA, Beilin LJ, Olynyk JK, Ayonrinde OT, Huang RC, Holt PG, Hart PH, Oddy WH, Adams LA. Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity. Journal of Gastroenterology and Hepatology. 29: 1215-22. PMID 24611991 DOI: 10.1111/jgh.12541 |
0.01 |
|
| 2014 |
Huang Y, de Boer WB, Adams LA, MacQuillan G, Bulsara MK, Jeffrey GP. Image analysis of liver biopsy samples measures fibrosis and predicts clinical outcome. Journal of Hepatology. 61: 22-7. PMID 24607623 DOI: 10.1016/j.jhep.2014.02.031 |
0.01 |
|
| 2014 |
Wong AT, Chan DC, Barrett PH, Adams LA, Watts GF. Effect of ω-3 fatty acid ethyl esters on apolipoprotein B-48 kinetics in obese subjects on a weight-loss diet: a new tracer kinetic study in the postprandial state. The Journal of Clinical Endocrinology and Metabolism. 99: E1427-35. PMID 24606094 DOI: 10.1210/jc.2013-4037 |
0.01 |
|
| 2014 |
OʼSullivan TA, Oddy WH, Bremner AP, Sherriff JL, Ayonrinde OT, Olynyk JK, Beilin LJ, Mori TA, Adams LA. Lower fructose intake may help protect against development of nonalcoholic fatty liver in adolescents with obesity. Journal of Pediatric Gastroenterology and Nutrition. 58: 624-31. PMID 24345826 DOI: 10.1097/MPG.0000000000000267 |
0.01 |
|
| 2014 |
Chinnaratha MA, Jeffrey GP, MacQuillan G, Rossi E, de Boer BW, Speers DJ, Adams LA. Prediction of morbidity and mortality in patients with chronic hepatitis C by non-invasive liver fibrosis models. Liver International : Official Journal of the International Association For the Study of the Liver. 34: 720-7. PMID 24034439 DOI: 10.1111/liv.12306 |
0.01 |
|
| 2014 |
Armstrong MJ, Adams LA, Canbay A, Syn WK. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.). 59: 1174-97. PMID 24002776 DOI: 10.1002/hep.26717 |
0.01 |
|
| 2014 |
Ma M, Adams L, Garas G, Macquillan G, O'dea M, Samuelson S, Tibballs J, Mac Nicholas R. P430 SELECTIVE INTERNAL RADIATION THERAPY FOR HEPATOCELLULAR CARCINOMA: COMBINATION WITH SORAFENIB IS ASSOCIATED WITH IMPROVED SURVIVAL OUTCOMES Journal of Hepatology. 60: S211. DOI: 10.1016/S0168-8278(14)60592-4 |
0.01 |
|
| 2014 |
Cruz ACD, Bugianesi E, George J, Day CP, Liaquat H, Charatcharoenwitthaya P, Mills PR, Dam-Larsen S, Bjornsson ES, Haflidadottir S, Adams LA, Bendtsen F, Angulo P. 379 Characteristics and Long-Term Prognosis of Lean Patients With Nonalcoholic Fatty Liver Disease Gastroenterology. 146: S-909. DOI: 10.1016/S0016-5085(14)63307-2 |
0.01 |
|
| 2013 |
Huang RC, Beilin LJ, Ayonrinde O, Mori TA, Olynyk JK, Burrows S, Hands B, Adams LA. Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents. Hepatology (Baltimore, Md.). 58: 1306-14. PMID 23703776 DOI: 10.1002/hep.26495 |
0.01 |
|
| 2013 |
Heeks LV, Hooper AJ, Adams LA, Robbins P, Barrett PH, van Bockxmeer FM, Burnett JR. Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemia. Clinica Chimica Acta; International Journal of Clinical Chemistry. 421: 121-5. PMID 23694813 DOI: 10.1016/j.cca.2013.03.004 |
0.01 |
|
| 2013 |
Huang Y, de Boer WB, Adams LA, MacQuillan G, Rossi E, Rigby P, Raftopoulos SC, Bulsara M, Jeffrey GP. Image analysis of liver collagen using sirius red is more accurate and correlates better with serum fibrosis markers than trichrome. Liver International : Official Journal of the International Association For the Study of the Liver. 33: 1249-56. PMID 23617278 DOI: 10.1111/liv.12184 |
0.01 |
|
| 2013 |
House MJ, Gan EK, Adams LA, Ayonrinde OT, Bangma SJ, Bhathal PS, Olynyk JK, St Pierre TG. Diagnostic performance of a rapid magnetic resonance imaging method of measuring hepatic steatosis. Plos One. 8: e59287. PMID 23555650 DOI: 10.1371/journal.pone.0059287 |
0.01 |
|
| 2013 |
Oddy WH, Herbison CE, Jacoby P, Ambrosini GL, O'Sullivan TA, Ayonrinde OT, Olynyk JK, Black LJ, Beilin LJ, Mori TA, Hands BP, Adams LA. The Western dietary pattern is prospectively associated with nonalcoholic fatty liver disease in adolescence. The American Journal of Gastroenterology. 108: 778-85. PMID 23545714 DOI: 10.1038/ajg.2013.95 |
0.01 |
|
| 2013 |
Yong K, Dogra G, Boudville N, Chan D, Adams L, Ching H, Lim EM, Lim WH. Interleukin-12 is associated with arterial stiffness in healthy individuals. American Journal of Hypertension. 26: 159-62. PMID 23382399 DOI: 10.1093/ajh/hps032 |
0.01 |
|
| 2013 |
Wong AT, Chan DC, Barrett PH, Adams LA, Watts GF. Supplementation with n3 fatty acid ethyl esters increases large and small artery elasticity in obese adults on a weight loss diet. The Journal of Nutrition. 143: 437-41. PMID 23365106 DOI: 10.3945/jn.112.169359 |
0.01 |
|
| 2013 |
Adams LA, White SW, Marsh JA, Lye SJ, Connor KL, Maganga R, Ayonrinde OT, Olynyk JK, Mori TA, Beilin LJ, Palmer LJ, Hamdorf JM, Pennell CE. Association between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.). 57: 590-600. PMID 23213074 DOI: 10.1002/hep.26184 |
0.01 |
|
| 2013 |
Rossi E, Adams LA, Ching HL, Bulsara M, MacQuillan GC, Jeffrey GP. High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosis. Clinical Chemistry and Laboratory Medicine : Cclm / Fescc. 51: 1107-14. PMID 23152415 DOI: 10.1515/cclm-2012-0584 |
0.01 |
|
| 2013 |
Adams LA. NAFLD in the Community Non-Alcoholic Fatty Liver Disease: a Practical Guide. 17-26. DOI: 10.1002/9781118556153.ch2 |
0.01 |
|
| 2012 |
Huang RC, Galati JC, Burrows S, Beilin LJ, Li X, Pennell CE, van Eekelen J, Mori TA, Adams LA, Craig JM. DNA methylation of the IGF2/H19 imprinting control region and adiposity distribution in young adults. Clinical Epigenetics. 4: 21. PMID 23148549 DOI: 10.1186/1868-7083-4-21 |
0.01 |
|
| 2012 |
Casey SP, Kemp WW, McLean CA, Topliss DJ, Adams LA, Roberts SK. A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver disease. Scandinavian Journal of Gastroenterology. 47: 836-41. PMID 22519948 DOI: 10.3109/00365521.2012.677955 |
0.01 |
|
| 2012 |
Adams LA, Marsh JA, Ayonrinde OT, Olynyk JK, Ang WQ, Beilin LJ, Mori T, Palmer LJ, Oddy WW, Lye SJ, Pennell CE. Cholesteryl ester transfer protein gene polymorphisms increase the risk of fatty liver in females independent of adiposity. Journal of Gastroenterology and Hepatology. 27: 1520-7. PMID 22414273 DOI: 10.1111/j.1440-1746.2012.07120.x |
0.01 |
|
| 2012 |
Treeprasertsuk S, Leverage S, Adams LA, Lindor KD, St Sauver J, Angulo P. The Framingham risk score and heart disease in nonalcoholic fatty liver disease. Liver International : Official Journal of the International Association For the Study of the Liver. 32: 945-50. PMID 22299674 DOI: 10.1111/j.1478-3231.2011.02753.x |
0.01 |
|
| 2012 |
Raftopoulos SC, George J, Bourliere M, Rossi E, de Boer WB, Jeffrey GP, Bulsara M, Speers DJ, MacQuillan G, Ching HL, Kontorinis N, Cheng W, Flexman J, Fermoyle S, Rigby P, ... ... Adams LA, et al. Comparison of noninvasive models of fibrosis in chronic hepatitis B. Hepatology International. 6: 457-67. PMID 21748376 DOI: 10.1007/s12072-011-9296-5 |
0.01 |
|
| 2012 |
Huang R, Mori T, Adams L, Burrows S, Ayonrinde O, Beilin L. 217 THE CARDIO-METABOLIC CLUSTER AS A DETERMINANT OF THE ASSOCIATION BETWEEN NON ALCOHOLIC FATTY LIVER DISEASE AND ARTERIAL STIFFNESS IN ADOLESCENTS Journal of Hypertension. 30: e66. DOI: 10.1097/01.hjh.0000420030.53458.d3 |
0.01 |
|
| 2012 |
Wallace M, Messineo A, Duffy S, Adams L, Jeffrey G, Speers D, de Boer B, Platten M, Cheng W, MacQuillan G. 546 VERY LOW ENDOGENOUS LEVELS OF HEPATOCELLULAR MXA PROTEIN SUGGESTS MINIMAL ACTIVATION OF THE TYPE I INTERFERON PATHWAY IN CHRONIC HBV DISEASE Journal of Hepatology. 56: S216-S217. DOI: 10.1016/S0168-8278(12)60559-5 |
0.01 |
|
| 2012 |
Holmes JA, Thompson AJ, Adams LA. Biomarkers of fibrosis and fibrosis progression in chronic hepatitis C Current Hepatitis Reports. 11: 231-242. DOI: 10.1007/s11901-012-0148-0 |
0.01 |
|
| 2011 |
Adams LA, George J, Bugianesi E, Rossi E, De Boer WB, van der Poorten D, Ching HL, Bulsara M, Jeffrey GP. Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology. 26: 1536-43. PMID 21950746 DOI: 10.1111/j.1440-1746.2011.06774.x |
0.01 |
|
| 2011 |
Smith BW, Adams LA. Non-alcoholic fatty liver disease. Critical Reviews in Clinical Laboratory Sciences. 48: 97-113. PMID 21875310 DOI: 10.3109/10408363.2011.596521 |
0.01 |
|
| 2011 |
Bhala N, Angulo P, van der Poorten D, Lee E, Hui JM, Saracco G, Adams LA, Charatcharoenwitthaya P, Topping JH, Bugianesi E, Day CP, George J. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology (Baltimore, Md.). 54: 1208-16. PMID 21688282 DOI: 10.1002/hep.24491 |
0.01 |
|
| 2011 |
Adams LA. Mortality in nonalcoholic fatty liver disease: clues from the Cremona study. Hepatology (Baltimore, Md.). 54: 6-8. PMID 21618568 DOI: 10.1002/hep.24445 |
0.01 |
|
| 2011 |
Smith BW, Adams LA. Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nature Reviews. Endocrinology. 7: 456-65. PMID 21556019 DOI: 10.1038/nrendo.2011.72 |
0.01 |
|
| 2011 |
Ayonrinde OT, Olynyk JK, Beilin LJ, Mori TA, Pennell CE, de Klerk N, Oddy WH, Shipman P, Adams LA. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease Hepatology. 53: 800-809. PMID 21374659 DOI: 10.1002/hep.24097 |
0.01 |
|
| 2011 |
Hooper AJ, Adams LA, Burnett JR. Genetic determinants of hepatic steatosis in man. Journal of Lipid Research. 52: 593-617. PMID 21245030 DOI: 10.1194/jlr.R008896 |
0.01 |
|
| 2011 |
Adams LA. Biomarkers of liver fibrosis. Journal of Gastroenterology and Hepatology. 26: 802-9. PMID 21198831 DOI: 10.1111/j.1440-1746.2010.06612.x |
0.01 |
|
| 2011 |
Adams LA, Feldstein AE. Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis. Journal of Digestive Diseases. 12: 10-6. PMID 21091933 DOI: 10.1111/j.1751-2980.2010.00471.x |
0.01 |
|
| 2010 |
Adams LA, Angulo P, Petz J, Keach J, Lindor KD. A pilot trial of high-dose ursodeoxycholic acid in nonalcoholic steatohepatitis. Hepatology International. 4: 628-33. PMID 21063487 DOI: 10.1007/s12072-010-9195-1 |
0.01 |
|
| 2010 |
Adams LA, Feldstein AE. Nonalcoholic steatohepatitis: risk factors and diagnosis. Expert Review of Gastroenterology & Hepatology. 4: 623-35. PMID 20932147 DOI: 10.1586/egh.10.56 |
0.01 |
|
| 2010 |
Lee S, Varano J, Flexman JP, Cheng W, Watson MW, Rossi E, Adams LA, Bulsara M, Price P. Decreased IP-10 and elevated TGFbeta1 levels are associated with viral clearance following therapy in patients with hepatitis C virus. Disease Markers. 28: 273-80. PMID 20592450 DOI: 10.3233/DMA-2010-0699 |
0.01 |
|
| 2010 |
Adams LA, Harmsen S, St Sauver JL, Charatcharoenwitthaya P, Enders FB, Therneau T, Angulo P. Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. The American Journal of Gastroenterology. 105: 1567-73. PMID 20145609 DOI: 10.1038/ajg.2010.18 |
0.01 |
|
| 2010 |
Adams L. Transient elastography in nonalcoholic fatty liver disease: making sense of echoes. Hepatology (Baltimore, Md.). 51: 370-2. PMID 20054871 DOI: 10.1002/hep.23422 |
0.01 |
|
| 2009 |
Thin L, Macquillan G, Adams L, Garas G, Seow C, Cannell P, Augustson B, Mitchell A, Delriveire L, Jeffrey G. Acute graft-versus-host disease after liver transplant: novel use of etanercept and the role of tumor necrosis factor alpha inhibitors. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 15: 421-6. PMID 19326415 DOI: 10.1002/lt.21704 |
0.01 |
|
| 2009 |
Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. The American Journal of Gastroenterology. 104: 861-7. PMID 19293782 DOI: 10.1038/ajg.2009.67 |
0.01 |
|
| 2009 |
Treeprasertsuk S, Angulo P, Adams LA, Lindor KD. 645 The Framingham Risk Score Accurately Predicts the Higher Risk of Coronary Heart Disease in Patients with Nonalcoholic Fatty Liver Disease Gastroenterology. 136: A-803. DOI: 10.1016/S0016-5085(09)63706-9 |
0.01 |
|
| 2008 |
Gan SK, Adams LA, Watts GF. The trials and tribulations of the treatment of nonalcoholic fatty-liver disease. Current Opinion in Lipidology. 19: 592-9. PMID 18957882 DOI: 10.1097/MOL.0b013e328317cc42 |
0.01 |
|
| 2008 |
Adams LA, Knuiman MW, Divitini ML, Olynyk JK. Body mass index is a stronger predictor of alanine aminotransaminase levels than alcohol consumption. Journal of Gastroenterology and Hepatology. 23: 1089-93. PMID 18557801 DOI: 10.1111/j.1440-1746.2008.05451.x |
0.01 |
|
| 2008 |
Mitchell A, Adams LA, MacQuillan G, Tibballs J, vanden Driesen R, Delriviere L. Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 14: 210-3. PMID 18236396 DOI: 10.1002/lt.21417 |
0.01 |
|
| 2008 |
Delriviere L, Thin L, Jeffrey G, MacQuillan G, Adams L, Garas G, Seow C. ACUTE GRAFT- VERUS- HOST- DISEASE POST ORTHOTOPIC LIVER TRANSPLANT: 2 CASES AND THE NOVEL USE OF ETANERCEPT. Transplantation. 86: 662. DOI: 10.1097/01.TP.0000330709.70459.CD |
0.01 |
|
| 2008 |
Adams LA, Mitchell A, MacQuillan G, Tibballs J, vanden Driesen R, Delriviere L. Reply: Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia Liver Transplantation. 14: 1687-1688. DOI: 10.1002/lt.21647 |
0.01 |
|
| 2007 |
Adams LA. Nonalcoholic fatty liver disease and diabetes mellitus. Endocrine Research. 32: 59-69. PMID 18092195 DOI: 10.1080/07435800701743885 |
0.01 |
|
| 2007 |
McCashland T, Watt K, Lyden E, Adams L, Charlton M, Smith AD, McGuire BM, Biggins SW, Neff G, Burton JR, Vargas H, Donovan J, Trotter J, Faust T. Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 13: 1246-53. PMID 17763405 DOI: 10.1002/Lt.21322 |
0.01 |
|
| 2007 |
Adams LA, Lindor KD. Nonalcoholic fatty liver disease. Annals of Epidemiology. 17: 863-9. PMID 17728149 DOI: 10.1016/j.annepidem.2007.05.013 |
0.01 |
|
| 2007 |
Rossi E, Adams LA, Bulsara M, Jeffrey GP. Assessing liver fibrosis with serum marker models. The Clinical Biochemist. Reviews / Australian Association of Clinical Biochemists. 28: 3-10. PMID 17603636 |
0.01 |
|
| 2007 |
Adams LA, Angulo P. Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease. Clinics in Liver Disease. 11: 25-35, viii. PMID 17544970 DOI: 10.1016/j.cld.2007.02.004 |
0.01 |
|
| 2007 |
Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, Enders F, Saksena S, Burt AD, Bida JP, Lindor K, Sanderson SO, Lenzi M, Adams LA, Kench J, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology (Baltimore, Md.). 45: 846-54. PMID 17393509 DOI: 10.1002/hep.21496 |
0.01 |
|
| 2007 |
Ayonrinde O, Adams L, Beilin L, Mori T, Shipman P, Sloan N, Oddy W, Olynyk J. P2-102 The prevalence and phenotypic characteristics of Western Australian adolescents with non-alcoholic fatty liver disease (NAFLD) Early Human Development. 83: S157-S158. DOI: 10.1016/S0378-3782(07)70435-8 |
0.01 |
|
| 2007 |
Ayonrinde O, Adams L, Beilin L, Mori T, Shipman P, Sloan N, Oddy W, Huang R, Newnham J, Stanley F, Olynyk J. P2-101 Developmental origins of non-alcoholic fatty liver (NAFL) Early Human Development. 83: S157. DOI: 10.1016/S0378-3782(07)70434-6 |
0.01 |
|
| 2007 |
Ayonrinde O, Adams L, Beilin L, Mori T, Shipman P, Oddy W, Sloan N, Stanley F, Olynyk J. P2-64 The influence of diet on development of non-alcoholic fatty liver (NAFL) Early Human Development. 83: S147. DOI: 10.1016/S0378-3782(07)70397-3 |
0.01 |
|
| 2006 |
Adams LA, Deboer B, Jeffrey G, Marley R, Garas G. Ganciclovir and the treatment of Epstein-Barr virus hepatitis. Journal of Gastroenterology and Hepatology. 21: 1758-60. PMID 16984606 DOI: 10.1111/j.1440-1746.2006.03257.x |
0.01 |
|
| 2006 |
Siah CW, Ombiga J, Adams LA, Trinder D, Olynyk JK. Normal iron metabolism and the pathophysiology of iron overload disorders. The Clinical Biochemist. Reviews / Australian Association of Clinical Biochemists. 27: 5-16. PMID 16886043 |
0.01 |
|
| 2006 |
Adams LA, Angulo P. Treatment of non-alcoholic fatty liver disease Postgraduate Medical Journal. 82: 315-322. PMID 16679470 DOI: 10.1136/pgmj.2005.042200 |
0.01 |
|
| 2006 |
Adams LA, Angulo P, Abraham SC, Torgerson H, Brandhagen D. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis. Liver International : Official Journal of the International Association For the Study of the Liver. 26: 298-304. PMID 16584391 DOI: 10.1111/j.1478-3231.2005.01238.x |
0.01 |
|
| 2006 |
Adams LA, Talwalkar JA. Diagnostic evaluation of nonalcoholic fatty liver disease. Journal of Clinical Gastroenterology. 40: S34-8. PMID 16540765 DOI: 10.1097/01.mcg.0000168642.38945.f1 |
0.01 |
|
| 2005 |
Adams LA, Angulo P. The bulge, booze, and the liver. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 3: 1195-7. PMID 16361044 DOI: 10.1016/S1542-3565(05)00892-X |
0.01 |
|
| 2005 |
Ombiga J, Adams LA, Tang K, Trinder D, Olynyk JK. Screening for HFE and iron overload. Seminars in Liver Disease. 25: 402-10. PMID 16315134 DOI: 10.1055/s-2005-923312 |
0.01 |
|
| 2005 |
Adams LA, Angulo P. Recent concepts in non-alcoholic fatty liver disease Diabetic Medicine. 22: 1129-1133. PMID 16108837 DOI: 10.1111/j.1464-5491.2005.01748.x |
0.01 |
|
| 2005 |
Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, Kench J, Farrell G, McCaughan GW, Jeffrey GP. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clinical Chemistry. 51: 1867-73. PMID 16055434 DOI: 10.1373/clinchem.2005.048389 |
0.01 |
|
| 2005 |
Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 129: 113-21. PMID 16012941 DOI: 10.1053/j.gastro.2005.04.014 |
0.01 |
|
| 2005 |
Feldstein AE, Papouchado BG, Angulo P, Sanderson S, Adams L, Gores GJ. Hepatic stellate cells and fibrosis progression in patients with nonalcoholic fatty liver disease. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 3: 384-9. PMID 15822044 DOI: 10.1016/S1542-3565(04)00616-0 |
0.01 |
|
| 2005 |
Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 172: 899-905. PMID 15795412 DOI: 10.1503/cmaj.045232 |
0.01 |
|
| 2005 |
Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. Journal of Hepatology. 42: 132-8. PMID 15629518 DOI: 10.1016/j.jhep.2004.09.012 |
0.01 |
|
| 2005 |
Adams LA. Nonalcoholic fatty liver disease Canadian Medical Association Journal. 173: 735-735. DOI: 10.1503/cmaj.1050114 |
0.01 |
|
| 2005 |
Adams LA, Angulo P. Insulin resistance, auto-antibodies, and nonalcoholic fatty liver disease response to letter [3] American Journal of Gastroenterology. 100: 1201-1202. DOI: 10.1111/j.1572-0241.2005.41837_4.x |
0.01 |
|
| 2004 |
Adams LA, Angulo P. Treatment of nonalcoholic steatohepatitis: antioxidants or insulin sensitizers? Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 2: 1059-60. PMID 15625648 DOI: 10.1016/S1542-3565(04)00462-8 |
0.01 |
|
| 2004 |
Angulo P, Alba LM, Petrovic LM, Adams LA, Lindor KD, Jensen MD. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. Journal of Hepatology. 41: 943-9. PMID 15582127 DOI: 10.1016/j.jhep.2004.08.020 |
0.01 |
|
| 2004 |
Adams LA, Zein CO, Angulo P, Lindor KD. A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. The American Journal of Gastroenterology. 99: 2365-8. PMID 15571584 DOI: 10.1111/j.1572-0241.2004.40064.x |
0.01 |
|
| 2004 |
Adams LA, Lindor KD. Treatment of hyperlipidemia in nonalcoholic fatty liver disease: fat for thought. Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology. 23: 127-8. PMID 15333965 |
0.01 |
|
| 2004 |
Adams LA, Lindor KD, Angulo P. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease. The American Journal of Gastroenterology. 99: 1316-20. PMID 15233671 DOI: 10.1111/j.1572-0241.2004.30444.x |
0.01 |
|
| 2004 |
Adams LA, Feldstein A, Lindor KD, Angulo P. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. Hepatology (Baltimore, Md.). 39: 909-14. PMID 15057893 DOI: 10.1002/hep.20140 |
0.01 |
|
| 2003 |
Adams LA, Angulo P. Vitamins E and C for the treatment of NASH: duplication of results but lack of demonstration of efficacy. The American Journal of Gastroenterology. 98: 2348-50. PMID 14638333 DOI: 10.1111/j.1572-0241.2003.08695.x |
0.01 |
|
| 2003 |
Rossi E, Adams L, Prins A, Bulsara M, de Boer B, Garas G, MacQuillan G, Speers D, Jeffrey G. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clinical Chemistry. 49: 450-4. PMID 12600957 DOI: 10.1373/49.3.450 |
0.01 |
|
| 2003 |
Adams L, Jeffrey GP, Deboer B, Garas G. Ticlopidine-associated cholestatic hepatitis. Internal Medicine Journal. 32: 359-60. PMID 12088359 DOI: 10.1046/j.1445-5994.2002.00241.x |
0.01 |
|
| 2003 |
ADAMS L, KEACH J, LINDOR K, ANGULO P. 731 Lipid profiles in nonalcoholic fatty liver disease Hepatology. 38: 512-512. DOI: 10.1016/S0270-9139(03)80773-5 |
0.01 |
|
| 2003 |
ADAMS L, FELDSTEIN A, LINDOR K, ANGULO P. 717 The spectrum of nonalcoholic fatty liver disease in patients with hypothalamic and pituitary dysfunction Hepatology. 38: 504-504. DOI: 10.1016/S0270-9139(03)80759-0 |
0.01 |
|
| 2003 |
ADAMS L, KEACH J, LINDOR K, ANGULO P. 714 Prevalence of autoantibodies and autoimmune hepatitis in nonalcoholic fatty liver disease Hepatology. 38: 503-503. DOI: 10.1016/S0270-9139(03)80756-5 |
0.01 |
|
| 2003 |
ADAMS L, KEACH J, LINDOR K, ANGULO P. 104 Time course of fibrosis progression in patients with nonalcoholic fatty liver disease Hepatology. 38: 206-207. DOI: 10.1016/S0270-9139(03)80147-7 |
0.01 |
|
| Hide low-probability matches. |